In SituGene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation

MLA

Moreno, Ana M., et al. “In SituGene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.” Molecular Therapy, vol. 28, no. 8, Aug. 2020, p. 1931. EBSCOhost, https://doi.org/10.1016/j.ymthe.2020.06.027.

APA

Moreno, A. M., Fu, X., Zhu, J., Katrekar, D., Shih, Y.-R. V., Marlett, J., Cabotaje, J., Tat, J., Naughton, J., Lisowski, L., Varghese, S., Zhang, K., & Mali, P. (2020). In SituGene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation. Molecular Therapy, 28(8), 1931. https://doi.org/10.1016/j.ymthe.2020.06.027

Chicago

Moreno, Ana M., Xin Fu, Jie Zhu, Dhruva Katrekar, Yu-Ru V. Shih, John Marlett, Jessica Cabotaje, et al. 2020. “In SituGene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.” Molecular Therapy 28 (8): 1931. doi:10.1016/j.ymthe.2020.06.027.